Rivaroxaban for treating pulmonary embolism and preventing recurrent venous thromboembolism

Technology appraisal guidance
Reference number: TA287
Published: 26 June 2013

Pulmonary embolism and recurrent venous thromboembolism - rivaroxaban: appendix A - matrix of stakeholders

Pulmonary embolism and recurrent venous thromboembolism - rivaroxaban: appendix A - matrix of stakeholders

Pulmonary embolism and recurrent venous thromboembolism - rivaroxaban: appendix A - matrix of stakeholders
12 May 2015
(99.61 Kb 29 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 11 May 2015